Tim Wilsdon and Ryan Lawlor are panelist during the session titled “Vaccines funding in Europe: Ensuring sustainability in a post-pandemic world.”
For more information on this event, click here.
Beyond the single asset: The rise of combination and synergistic innovation in neurology drug development
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...